For example, the common polymorphism in SOD2 (SOD2V16A) in patients with sickle cell disease associates with increased cardiovascular consequences by curtailing mitochondrial complex IV activity and increasing ROS production (149, 150). Here, SOD2 is linked to sickle cell disease.